These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23101150)

  • 1. Kidney stone disease: pathophysiology, investigation and medical treatment.
    Dawson CH; Tomson CR
    Clin Med (Lond); 2012 Oct; 12(5):467-71. PubMed ID: 23101150
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium oxalate kidney stones: another reason to encourage moderate calcium intakes and other dietary changes.
    Moyad MA
    Urol Nurs; 2003 Aug; 23(4):310-3. PubMed ID: 14552081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal calcium excretion and urolithiasis].
    Aruga S; Honma Y
    Clin Calcium; 2011 Oct; 21(10):1465-72. PubMed ID: 21960231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growing prevalence of kidney stones and opportunities for prevention.
    Richman K; O'Bell J; Pareek G
    R I Med J (2013); 2014 Dec; 97(12):31-4. PubMed ID: 25463625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metaphylaxis of recurrent renal calcium stones].
    Pasch A
    Ther Umsch; 2007 May; 64(5):253-8. PubMed ID: 17685083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH; Coe FL; Evan AP; Worcester EM
    BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.
    Spivacow FR; Negri AL; del Valle EE; Fradinger E; Martinez C; Polonsky A
    Int Urol Nephrol; 2012 Jun; 44(3):857-63. PubMed ID: 21505756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
    Ferraro PM; Robertson WG; Johri N; Nair A; Gambaro G; Shavit L; Moochhala SH; Unwin RJ
    QJM; 2015 Jul; 108(7):561-8. PubMed ID: 25524906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary calcium, dietary protein, and kidney stone formation.
    Curhan GC
    Miner Electrolyte Metab; 1997; 23(3-6):261-4. PubMed ID: 9387129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic investigation of calcium renal lithiasis in adults and therapeutic advice].
    Paillard M
    J Urol (Paris); 1989; 95(7):387-92. PubMed ID: 2592778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet and nephrolithiasis.
    Goldfarb S
    Annu Rev Med; 1994; 45():235-43. PubMed ID: 8198380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How useful is an oral calcium load test for diagnosing recurrent calcium stone formers?
    Tostivint IN; Castiglione V; Alkouri R; Bertocchio JP; Inaoui R; Daudon M; Dousseaux MP; Cavalier E; Pieroni L; Izzedine H
    Urolithiasis; 2022 Oct; 50(5):577-587. PubMed ID: 35994082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
    J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dietary modification on urinary stone risk factors.
    Taylor EN; Curhan GC
    Kidney Int; 2006 Mar; 69(6):1093. PubMed ID: 16528260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dietary calcium and kidney stone formation].
    Dtsch Med Wochenschr; 1993 Nov; 118(44):1627. PubMed ID: 8223221
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical diagnosis in 3040 kidney stone formers in Argentina.
    Spivacow FR; del Valle EE; Negri AL; Fradinger E; Abib A; Rey P
    Urolithiasis; 2015 Aug; 43(4):323-30. PubMed ID: 25958053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal stone disease: Causes, evaluation and medical treatment.
    Heilberg IP; Schor N
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):823-31. PubMed ID: 17117307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrolithiasis due to primary hyperparathyroidism and enteric hyperoxaluria: a case report.
    Hardwick C; Assimos DG
    Urology; 1996 May; 47(5):751-5. PubMed ID: 8650879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.